Khoom Description
INCI Lub Npe: Lanreotide Acetate
Cas No: 108736-35-2
Cov roj formula: C54H69N11O10S2
Molecular Luj: 1096.34
Sequence: HD-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2
Purity: >99 feem pua
Tau qhov twg los: Synthetic
Qib: Tshuaj pleev ib ce
Stability: ruaj khov
Solubility: me ntsis soluble hauv dej
Formulation: Muaj rau koj siv, thov hu rau peb
MSDS thiab COA: Muaj rau koj siv, thov hu rau peb
Cov tsos mob: Dawb Lyophilized hmoov
Cia: Tom qab reconstitution khw ntawm 2 degree - 8 degree
Nqe lus piav qhia:
Lanreotide yog qhia rau kev kho mob mus sij hawm ntev ntawm cov neeg mob acromegalic uas tau teb tsis txaus rau kev phais thiab / orradiotherapy, lossis rau leej twg phais thiab / lossis kev kho mob hluav taws xob tsis yog ib qho kev xaiv.
Lub hom phiaj ntawm kev kho mob hauv acromegaly yog txo qis (GH) thiab insuli kev loj hlob zoo tshaj -1 qib mus rau qhov qub.
Muaj nuj nqi
1) Kev kho mob ntawm acromegaly
(2) Kev kho qee yam qog
(3) Radiolabeling hauv Nuclear Tshuaj Imaging
(4) Tswj cov ntshav esophageal varices
(5) Kev rog rog
(6) Kev kho mob plab plab Fistula
Qhia meej
Peb peptides tsuas yog siv rau Kev Tshawb Fawb & Lab, tsis siv rau tib neeg lub cev.
Lub peev xwm ua tau zoo thiab daim ntawv thov koom nrog hauv kev qhia txog cov khoom lag luam yog tag nrho los ntawm cov ntaub ntawv luam tawm, uas tsis tau raug soj ntsuam los ntawm Lub Xeev Food and Drug Administration, thiab tsuas yog siv rau kev siv, tsis yog rau lub hauv paus tiag tiag.
Cim npe nrov: 99.0 feem pua min. lanreotide acetate lyophilized hmoov, Tuam Tshoj, manufacturers, lwm tus neeg, Hoobkas, pheej yig, luv nqi, hais, luv nqi, dawb qauv
